Resolute Wealth Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$679K Buy
2,778
+159
+6% +$37K 0.29% 46
2025
Q4
$542K Sell
2,619
-33
-1% -$6.53K 0.24% 57
2025
Q3
$492K Sell
2,652
-239
-8% -$40.9K 0.23% 60
2025
Q2
$442K Buy
2,891
+7
+0.2% +$1.08K 0.24% 66
2025
Q1
$478K Buy
2,884
+972
+51% +$152K 0.27% 56
2024
Q4
$277K Sell
1,912
-191
-9% -$29.6K 0.14% 83
2024
Q3
$341K Buy
2,103
+5
+0.2% +$797 0.18% 72
2024
Q2
$307K Sell
2,098
-84
-4% -$12.5K 0.18% 68
2024
Q1
$345K Buy
2,182
+9
+0.4% +$1.43K 0.21% 68
2023
Q4
$341K Buy
2,173
+8
+0.4% +$1.23K 0.23% 63
2023
Q3
$337K Buy
2,165
+9
+0.4% +$1.49K 0.25% 60
2023
Q2
$357K Buy
2,156
+122
+6% +$19.7K 0.28% 60
2023
Q1
$315K Buy
+2,034
New +$328K 0.27% 63

Other funds holding JNJ

Resolute Wealth Strategies's JNJ Position: Q1 2026 in Review

Resolute Wealth Strategies increased its Johnson & Johnson (JNJ) stake by 6.1% in Q1 2026, buying an estimated $37K and bringing the position to 2,778 shares worth $679K. The position accounts for 0.29% of the portfolio, ranked #46.

Resolute Wealth Strategies first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Resolute Wealth Strategies held 2,778 shares of Johnson & Johnson worth $679K as of Q1 2026.
  • Resolute Wealth Strategies bought 159 Johnson & Johnson shares in Q1 2026, an estimated $37K.
  • Johnson & Johnson made up 0.29% of Resolute Wealth Strategies's portfolio in Q1 2026, its #46 holding.
  • Resolute Wealth Strategies first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Resolute Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.